{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T14:48:48Z","timestamp":1764859728943,"version":"3.44.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,13]]},"DOI":"10.7759\/cureus.92230","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T17:44:25Z","timestamp":1757785465000},"source":"Crossref","is-referenced-by-count":1,"title":["From the Gut to the Bone: A Narrative Review of the Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO)-Inflammatory Bowel Disease (IBD) Overlap Syndrome"],"prefix":"10.7759","author":[{"given":"Abdulrahman A","family":"Almalaq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulaziz","family":"Almasoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebtissam","family":"Almeghaiseeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem","family":"Alamro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah M","family":"Albishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seham","family":"Alrashidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman","family":"Alrobayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"[Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]","volume":"54","author":"Chamot AM","year":"1987","unstructured":"Chamot AM, Benhamou CL, Kahn MF, Beraneck L, Kaplan G, Prost A. [Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases]. Rev Rhum Mal Osteoartic. 1987, 54:187-96.","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"ref2","article-title":"[SAPHO syndrome]","volume":"54","author":"Hayem G","year":"2004","unstructured":"Hayem G. [SAPHO syndrome]. Rev Prat. 2004, 54:1635-6.","journal-title":"Rev Prat"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0950-3579(94)80022-7","article-title":"The SAPHO syndrome","volume":"8","author":"Kahn MF","year":"1994","unstructured":"Kahn MF, Khan MA. The SAPHO syndrome. Baillieres Clin Rheumatol. 1994, 8:333-62. 10.1016\/s0950-3579(94)80022-7","journal-title":"Baillieres Clin Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2653-6","article-title":"A systematic review of SAPHO syndrome and inflammatory bowel disease association","volume":"58","author":"Naves JE","year":"2013","unstructured":"Naves JE, Cabr\u00e9 E, Ma\u00f1osa M, Grados D, Oliv\u00e9 A, Dom\u00e8nech E. A systematic review of SAPHO syndrome and inflammatory bowel disease association. Dig Dis Sci. 2013, 58:2138-47. 10.1007\/s10620-013-2653-6","journal-title":"Dig Dis Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.33590\/emjgastroenterol\/10303080","article-title":"SAPHO syndrome in Crohn\u2019s disease successfully treated with ustekinumab: case report and review of the literature","author":"Caporuscio S","year":"2023","unstructured":"Caporuscio S, Maggi D, Aratari A, Papi C, Festa S. SAPHO syndrome in Crohn\u2019s disease successfully treated with ustekinumab: case report and review of the literature. EMJ Gastroenterol. 2023, 10.33590\/emjgastroenterol\/10303080","journal-title":"EMJ Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14309\/crj.0000000000001342","article-title":"Refractory ulcerative colitis with associated synovitis, acne, pustulosis, hyperostosis, osteitis syndrome successfully treated with tofacitinib","volume":"11","author":"Kim BJ","year":"2024","unstructured":"Kim BJ, Thiemann A, Dietz B, Beck K. Refractory ulcerative colitis with associated synovitis, acne, pustulosis, hyperostosis, osteitis syndrome successfully treated with tofacitinib. ACG Case Rep J. 2024, 11:e01342. 10.14309\/crj.0000000000001342","journal-title":"ACG Case Rep J"},{"key":"ref7","article-title":"Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies?","volume":"6","author":"Benhamou CL","year":"1988","unstructured":"Benhamou CL, Chamot AM, Kahn MF. Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies?. Clin Exp Rheumatol. 1988, 6:109-12.","journal-title":"Clin Exp Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease","volume":"10","author":"Harbord M","year":"2016","unstructured":"Harbord M, Annese V, Vavricka SR, et al.. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016, 10:239-54. 10.1093\/ecco-jcc\/jjv213","journal-title":"J Crohns Colitis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka SR","year":"2015","unstructured":"Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015, 21:1982-92. 10.1097\/MIB.0000000000000392","journal-title":"Inflamm Bowel Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.29271\/jcpsp.2019.07.671","article-title":"SAPHO syndrome in an adult male with ulcerative colitis","volume":"29","author":"Sayeed S","year":"2019","unstructured":"Sayeed S, Imtiaz A, Naz F. SAPHO syndrome in an adult male with ulcerative colitis. J Coll Physicians Surg Pak. 2019, 29:671-3. 10.29271\/jcpsp.2019.07.671","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/3558853","article-title":"Enteropathic SAPHO syndrome in ulcerative colitis responsive to bisphosphonates","volume":"2024","author":"Phillipps J","year":"2024","unstructured":"Phillipps J, Mumtaz S, Valecha J, Stanborough RO, Berianu F, Abate E, Majithia V. Enteropathic SAPHO syndrome in ulcerative colitis responsive to bisphosphonates. Case Rep Rheumatol. 2024, 2024:3558853. 10.1155\/2024\/3558853","journal-title":"Case Rep Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2011.01.017","article-title":"The SAPHO syndrome--are microbes involved?","volume":"25","author":"Assmann G","year":"2011","unstructured":"Assmann G, Simon P. The SAPHO syndrome--are microbes involved?. Best Pract Res Clin Rheumatol. 2011, 25:423-34. 10.1016\/j.berh.2011.01.017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14041366","article-title":"What is new and what is next for SAPHO syndrome management: a narrative review","volume":"14","author":"Ferraioli M","year":"2025","unstructured":"Ferraioli M, Levani J, De Luca R, et al.. What is new and what is next for SAPHO syndrome management: a narrative review. J Clin Med. 2025, 14:10.3390\/jcm14041366","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/art.24540","article-title":"Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects","volume":"61","author":"Colina M","year":"2009","unstructured":"Colina M, Govoni M, Orzincolo C, Trotta F. Clinical and radiologic evolution of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a single center study of a cohort of 71 subjects. Arthritis Rheum. 2009, 61:813-21. 10.1002\/art.24540","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-48382-3_69","article-title":"A case of SAPHO syndrome with pyoderma gangrenosum and inflammatory bowel disease masquerading as Beh\u00e7et's disease","volume":"528","author":"Yamasaki O","year":"2003","unstructured":"Yamasaki O, Iwatsuki K, Kaneko F. A case of SAPHO syndrome with pyoderma gangrenosum and inflammatory bowel disease masquerading as Beh\u00e7et's disease. Adv Exp Med Biol. 2003, 528:339-41. 10.1007\/0-306-48382-3_69","journal-title":"Adv Exp Med Biol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-009-1021-5","article-title":"SAPHO syndrome in an adult with ulcerative colitis responsive to intravenous pamidronate: a case report and review of the literature","volume":"30","author":"Siau K","year":"2010","unstructured":"Siau K, Laversuch CJ. SAPHO syndrome in an adult with ulcerative colitis responsive to intravenous pamidronate: a case report and review of the literature. Rheumatol Int. 2010, 30:1085-8. 10.1007\/s00296-009-1021-5","journal-title":"Rheumatol Int"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4083-5","article-title":"Paradoxical skin lesions induced by anti-TNF-\u03b1 agents in SAPHO syndrome","volume":"38","author":"Li C","year":"2019","unstructured":"Li C, Wu X, Cao Y, et al.. Paradoxical skin lesions induced by anti-TNF-\u03b1 agents in SAPHO syndrome. Clin Rheumatol. 2019, 38:53-61. 10.1007\/s10067-018-4083-5","journal-title":"Clin Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2018.09.001","article-title":"SAPHO syndrome in pediatric patients with inflammatory bowel disease treated with infliximab","volume":"50","author":"Marrani E","year":"2018","unstructured":"Marrani E, Belli G, Simonini G, Trapani S, Caproni M, Lionetti P. SAPHO syndrome in pediatric patients with inflammatory bowel disease treated with infliximab. Dig Liver Dis. 2018, 50:1249-51. 10.1016\/j.dld.2018.09.001","journal-title":"Dig Liver Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1427784","article-title":"The role of cytokines in the pathogenesis of SAPHO syndrome","volume":"15","author":"Yang Y","year":"2024","unstructured":"Yang Y, Chen Q, Zhong W. The role of cytokines in the pathogenesis of SAPHO syndrome. Front Immunol. 2024, 15:1427784. 10.3389\/fimmu.2024.1427784","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201810001-02055","article-title":"A case of pyoderma gangrenosum as skin manifestation of SAPHO syndrome in an IBD patient","volume":"113","author":"Kang M","year":"2018","unstructured":"Kang M, Navabi S, Baragona A, Manzo C, Tinsley A, Williams E, Bethards D. A case of pyoderma gangrenosum as skin manifestation of SAPHO syndrome in an IBD patient. Am J Gastroenterol. 2018, 113:S1171-2.","journal-title":"Am J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3109\/03009749609069220","article-title":"An aseptic inflammation of the clavicle in a patient with Crohn's disease. A potential manifestation of the SAPHO syndrome","volume":"25","author":"Kotilainen PM","year":"1996","unstructured":"Kotilainen PM, Laxen FO, Manner IK, Gullichsen RE, Saario RM. An aseptic inflammation of the clavicle in a patient with Crohn's disease. A potential manifestation of the SAPHO syndrome. Scand J Rheumatol. 1996, 25:112-4. 10.3109\/03009749609069220","journal-title":"Scand J Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0399-8320(07)89438-3","article-title":"[Crohn's disease and the SAPHO syndrome during treatment with infliximab: a case report and review of literature]","volume":"31","author":"Van Den Eynde M","year":"2007","unstructured":"Van Den Eynde M, Lecluyse K, Chioccioli C, Brouckaert M, Caussin E, Lammens P. [Crohn's disease and the SAPHO syndrome during treatment with infliximab: a case report and review of literature]. Gastroenterol Clin Biol. 2007, 31:607-10. 10.1016\/s0399-8320(07)89438-3","journal-title":"Gastroenterol Clin Biol"},{"key":"ref23","article-title":"[The synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome, a rare extra-digestive manifestation of Crohn's disease. Presentation of 1 case and review of the literature]","volume":"22","author":"Dharancy S","year":"1998","unstructured":"Dharancy S, Talbodec N, Asselah T, Hachulla E, Delaporte E, Cortot A, Colombel JF. [The synovitis-acne-pustulosis-hyperostosis-osteitis (SAPHO) syndrome, a rare extra-digestive manifestation of Crohn's disease. Presentation of 1 case and review of the literature]. Gastroenterol Clin Biol. 1998, 22:240-3.","journal-title":"Gastroenterol Clin Biol"},{"key":"ref24","article-title":"[Chronic enterocolopathies and SAPHO syndrome. 8 cases]","volume":"59","author":"Kahn MF","year":"1992","unstructured":"Kahn MF, Bouchon JP, Chamot AM, Palazzo E. [Chronic enterocolopathies and SAPHO syndrome. 8 cases]. Rev Rhum Mal Osteoartic. 1992, 59:91-4.","journal-title":"Rev Rhum Mal Osteoartic"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s11832-014-0627-7","article-title":"SAPHO syndrome: a review","volume":"9","author":"Rukavina I","year":"2015","unstructured":"Rukavina I. SAPHO syndrome: a review. J Child Orthop. 2015, 9:19-27. 10.1007\/s11832-014-0627-7","journal-title":"J Child Orthop"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140342","article-title":"The SAPHO syndrome: a single-center study of 41 adult patients","volume":"42","author":"Aljuhani F","year":"2015","unstructured":"Aljuhani F, Tournadre A, Tatar Z, et al.. The SAPHO syndrome: a single-center study of 41 adult patients. J Rheumatol. 2015, 42:329-34. 10.3899\/jrheum.140342","journal-title":"J Rheumatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2017.1372874","article-title":"Clinical features and radiological findings of 67 patients with SAPHO syndrome","volume":"28","author":"Okuno H","year":"2018","unstructured":"Okuno H, Watanuki M, Kuwahara Y, et al.. Clinical features and radiological findings of 67 patients with SAPHO syndrome. Mod Rheumatol. 2018, 28:703-8. 10.1080\/14397595.2017.1372874","journal-title":"Mod Rheumatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.211155","article-title":"Off-label use of secukinumab: a potential therapeutic option for SAPHO syndrome","volume":"49","author":"Wang G","year":"2022","unstructured":"Wang G, Zhuo N, Li J. Off-label use of secukinumab: a potential therapeutic option for SAPHO syndrome. J Rheumatol. 2022, 49:656. 10.3899\/jrheum.211155","journal-title":"J Rheumatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee S","year":"2017","unstructured":"Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM. JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs. 2017, 77:521-46. 10.1007\/s40265-017-0701-9","journal-title":"Drugs"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112168","article-title":"Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis","volume":"367","author":"Sandborn WJ","year":"2012","unstructured":"Sandborn WJ, Ghosh S, Panes J, Vranic I, Su C, Rousell S, Niezychowski W. Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis. N Engl J Med. 2012, 367:616-24. 10.1056\/NEJMoa1112168","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-012-0239-5","article-title":"Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis","volume":"14","author":"Ferguson PJ","year":"2012","unstructured":"Ferguson PJ, Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep. 2012, 14:130-41. 10.1007\/s11926-012-0239-5","journal-title":"Curr Rheumatol Rep"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2016.09.028","article-title":"A systematic analysis of treatment and outcomes of NOD2-associated autoinflammatory disease","volume":"130","author":"Yao Q","year":"2017","unstructured":"Yao Q, Shen B. A systematic analysis of treatment and outcomes of NOD2-associated autoinflammatory disease. Am J Med. 2017, 130:365.e13-8. 10.1016\/j.amjmed.2016.09.028","journal-title":"Am J Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-014-1460-6","article-title":"[SAPHO syndrome]","volume":"73","author":"Heldmann F","year":"2014","unstructured":"Heldmann F, Kiltz U, Baraliakos X, Braun J. [SAPHO syndrome]. Z Rheumatol. 2014, 73:729-41. 10.1007\/s00393-014-1460-6","journal-title":"Z Rheumatol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2174\/1874325000903010100","article-title":"SAPHO syndrome diagnosis and treatment: report of five cases and review of the literature","volume":"3","author":"Matzaroglou Ch","year":"2009","unstructured":"Matzaroglou Ch, Velissaris D, Karageorgos A, Marangos M, Panagiotopoulos E, Karanikolas M. SAPHO syndrome diagnosis and treatment: report of five cases and review of the literature. Open Orthop J. 2009, 3:100-6. 10.2174\/1874325000903010100","journal-title":"Open Orthop J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s003930050001","article-title":"[SAPHO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases]","volume":"59","author":"Schilling F","year":"2000","unstructured":"Schilling F, KesslerS. [SAPHO syndrome: clinico-rheumatologic and radiologic differentiation and classification of a patient sample of 86 cases]. Z Rheumatol. 2000, 59:1-28. 10.1007\/s003930050001","journal-title":"Z Rheumatol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2023.12.019","article-title":"Prevalence and features of chronic nonbacterial osteomyelitis in a cohort of children with inflammatory bowel diseases","volume":"56","author":"Scarallo L","year":"2024","unstructured":"Scarallo L, Knafelz D, Arrigo S, Felici E, Lionetti P. Prevalence and features of chronic nonbacterial osteomyelitis in a cohort of children with inflammatory bowel diseases. Dig Liver Dis. 2024, 56:537-9. 10.1016\/j.dld.2023.12.019","journal-title":"Dig Liver Dis"},{"key":"ref37","article-title":"Gastric Crohn's disease and SAPHO syndrome","volume":"19","author":"Girelli CM","year":"2001","unstructured":"Girelli CM, Scarpellini M. Gastric Crohn's disease and SAPHO syndrome. Clin Exp Rheumatol. 2001, 19:356.","journal-title":"Clin Exp Rheumatol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3689","article-title":"Multimodal imaging findings of SAPHO syndrome with no skin lesions: a report of three cases and review of the literature","volume":"12","author":"Duan N","year":"2016","unstructured":"Duan N, Chen X, Liu Y, Wang J, Wang Z. Multimodal imaging findings of SAPHO syndrome with no skin lesions: a report of three cases and review of the literature. Exp Ther Med. 2016, 12:2665-70. 10.3892\/etm.2016.3689","journal-title":"Exp Ther Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.14309\/01.ajg.0000962488.83214.13","article-title":"S3212 Sweet and SAPHO: rare overlapping extraintestinal manifestations of inflammatory bowel disease","volume":"118","author":"Chadalawada S","year":"2023","unstructured":"Chadalawada S, Roe-\u017dur\u017e Z, Clark L, Liu B`. S3212 Sweet and SAPHO: rare overlapping extraintestinal manifestations of inflammatory bowel disease. Am J Gastroenterol. 2023, 118:S2140-1. 10.14309\/01.ajg.0000962488.83214.13","journal-title":"Am J Gastroenterol"},{"key":"ref40","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-200709002-00567","article-title":"Rare extra-intestinal manifestation of ulcerative colitis: 567","volume":"102","author":"Smith J","year":"2007","unstructured":"Smith J, Newton EB, Protiva P. Rare extra-intestinal manifestation of ulcerative colitis: 567. Am J Gastroenterol. 2007, 102:S325.","journal-title":"Am J Gastroenterol"},{"key":"ref41","article-title":"SAPHO syndrome and pyoderma gangrenosum: is it fortuitous?","volume":"23","author":"Claudepierre P","year":"1996","unstructured":"Claudepierre P, Clerc D, Cariou D, Lavabre C, Venencie PY, Bisson M. SAPHO syndrome and pyoderma gangrenosum: is it fortuitous?. J Rheumatol. 1996, 23:400-2.","journal-title":"J Rheumatol"},{"key":"ref42","article-title":"A case of non-malignant multifocal lesions on the methyl diphosphonate technetium-99m bone scan with enteropathy. SAPHO syndrome","volume":"10","author":"Skoura E","year":"2007","unstructured":"Skoura E, Giannopoulou C, Zaromytidou E, Pianou N, Houssianakou I. A case of non-malignant multifocal lesions on the methyl diphosphonate technetium-99m bone scan with enteropathy. SAPHO syndrome. Hell J Nucl Med. 2007, 10:26-8.","journal-title":"Hell J Nucl Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2020.97394","article-title":"SAPHO syndrome: pathogenesis, clinical presentation, imaging, comorbidities and treatment: a review","volume":"38","author":"Przepiera-B\u0119dzak H","year":"2021","unstructured":"Przepiera-B\u0119dzak H, Brzosko M. SAPHO syndrome: pathogenesis, clinical presentation, imaging, comorbidities and treatment: a review. Postepy Dermatol Alergol. 2021, 38:937-42. 10.5114\/ada.2020.97394","journal-title":"Postepy Dermatol Alergol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-003-0629-x","article-title":"SAPHO: syndrome or concept? Imaging findings","volume":"32","author":"Earwaker JW","year":"2003","unstructured":"Earwaker JW, Cotten A. SAPHO: syndrome or concept? Imaging findings. Skeletal Radiol. 2003, 32:311-27. 10.1007\/s00256-003-0629-x","journal-title":"Skeletal Radiol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02309-6","article-title":"Anterior chest wall in SAPHO syndrome: magnetic resonance imaging findings","volume":"22","author":"Yu M","year":"2020","unstructured":"Yu M, Cao Y, Li J, et al.. Anterior chest wall in SAPHO syndrome: magnetic resonance imaging findings. Arthritis Res Ther. 2020, 22:216. 10.1186\/s13075-020-02309-6","journal-title":"Arthritis Res Ther"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2023.e01784","article-title":"Clinical spectrum of Cutibacterium acnes infections: the SAPHO syndrome","volume":"32","author":"Corbisiero MF","year":"2023","unstructured":"Corbisiero MF, Batta N, Kyllo H, Smyth A, Allen L, Franco-Paredes C. Clinical spectrum of Cutibacterium acnes infections: the SAPHO syndrome. IDCases. 2023, 32:e01784. 10.1016\/j.idcr.2023.e01784","journal-title":"IDCases"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090863","article-title":"Prevalence of autoantibodies in SAPHO syndrome: a single-center study of 90 patients","volume":"37","author":"Grosjean C","year":"2010","unstructured":"Grosjean C, Hurtado-Nedelec M, Nicaise-Roland P, et al.. Prevalence of autoantibodies in SAPHO syndrome: a single-center study of 90 patients. J Rheumatol. 2010, 37:639-43. 10.3899\/jrheum.090863","journal-title":"J Rheumatol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.04.030","article-title":"Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome - a\u00a0challenging diagnosis not to be missed","volume":"72 Suppl","author":"Zimmermann P","year":"2016","unstructured":"Zimmermann P, Curtis N. Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome - a\u00a0challenging diagnosis not to be missed. J Infect. 2016, 72 Suppl:S106-14. 10.1016\/j.jinf.2016.04.030","journal-title":"J Infect"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2017.1416733","article-title":"Clinical heterogeneity of SAPHO syndrome: challenge of diagnosis","volume":"28","author":"Li C","year":"2018","unstructured":"Li C, Cao Y, Zhang W. Clinical heterogeneity of SAPHO syndrome: challenge of diagnosis. Mod Rheumatol. 2018, 28:432-4. 10.1080\/14397595.2017.1416733","journal-title":"Mod Rheumatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20912865","article-title":"Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update","volume":"12","author":"Liu S","year":"2020","unstructured":"Liu S, Tang M, Cao Y, Li C. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: review and update. Ther Adv Musculoskelet Dis. 2020, 12:1759720X20912865. 10.1177\/1759720X20912865","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003688","article-title":"Treatment and monitoring of SAPHO syndrome: a systematic review","volume":"9","author":"Li SW","year":"2023","unstructured":"Li SW, Roberts E, Hedrich C. Treatment and monitoring of SAPHO syndrome: a systematic review. RMD Open. 2023, 9:10.1136\/rmdopen-2023-003688","journal-title":"RMD Open"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1560398","article-title":"Therapeutic approaches for SAPHO syndrome from the perspective of pathogenesis: a review of the literature","volume":"16","author":"Wang Y","year":"2025","unstructured":"Wang Y, Gu M, Zheng Z, et al.. Therapeutic approaches for SAPHO syndrome from the perspective of pathogenesis: a review of the literature. Front Immunol. 2025, 16:1560398. 10.3389\/fimmu.2025.1560398","journal-title":"Front Immunol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1002\/art.20464","article-title":"Successful treatment of SAPHO syndrome with zoledronic acid","volume":"50","author":"Kopterides P","year":"2004","unstructured":"Kopterides P, Pikazis D, Koufos C. Successful treatment of SAPHO syndrome with zoledronic acid. Arthritis Rheum. 2004, 50:2970-3. 10.1002\/art.20464","journal-title":"Arthritis Rheum"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05491-3","article-title":"SAPHO syndrome: current clinical, diagnostic and treatment approaches","volume":"44","author":"Demirci Yildirim T","year":"2024","unstructured":"Demirci Yildirim T, Sari \u0130. SAPHO syndrome: current clinical, diagnostic and treatment approaches. Rheumatol Int. 2024, 44:2301-13. 10.1007\/s00296-023-05491-3","journal-title":"Rheumatol Int"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.04.004","article-title":"SAPHO: treatment options including bisphosphonates","volume":"46","author":"Zwaenepoel T","year":"2016","unstructured":"Zwaenepoel T, Vlam K. SAPHO: treatment options including bisphosphonates. Semin Arthritis Rheum. 2016, 46:168-73. 10.1016\/j.semarthrit.2016.04.004","journal-title":"Semin Arthritis Rheum"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmhi.2015.04.002","article-title":"Implication of bisphosphonate use in the treatment of SAPHO syndrome: case report and discussion of current literature","volume":"9","author":"Gorecki P","year":"2015","unstructured":"Gorecki P, Stockmann P, Distler J. Implication of bisphosphonate use in the treatment of SAPHO syndrome: case report and discussion of current literature. J Med Hypotheses Ideas. 2015, 9:72-8. 10.1016\/j.jmhi.2015.04.002","journal-title":"J Med Hypotheses Ideas"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66169","article-title":"Successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with tofacitinib: a case report","volume":"16","author":"Alhayali M","year":"2024","unstructured":"Alhayali M. Successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome with tofacitinib: a case report. Cureus. 2024, 16:e66169. 10.7759\/cureus.66169","journal-title":"Cureus"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis suppurativa: advances in diagnosis and treatment","volume":"318","author":"Saunte DM","year":"2017","unstructured":"Saunte DM, Jemec GB. Hidradenitis suppurativa: advances in diagnosis and treatment. JAMA. 2017, 318:2019-32. 10.1001\/jama.2017.16691","journal-title":"JAMA"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200809010-00001","article-title":"Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients","volume":"9","author":"Wollina U","year":"2008","unstructured":"Wollina U, Hansel G, Koch A, Sch\u00f6nlebe J, K\u00f6stler E, Haroske G. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. Am J Clin Dermatol. 2008, 9:1-14. 10.2165\/00128071-200809010-00001","journal-title":"Am J Clin Dermatol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10020455","article-title":"Paradoxical hidradenitis suppurativa during biologic therapy, an emerging challenge: a systematic review","volume":"10","author":"Ruggiero A","year":"2022","unstructured":"Ruggiero A, Martora F, Picone V, Marano L, Fabbrocini G, Marasca C. Paradoxical hidradenitis suppurativa during biologic therapy, an emerging challenge: a systematic review. Biomedicines. 2022, 10:10.3390\/biomedicines10020455","journal-title":"Biomedicines"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13740","article-title":"SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature","volume":"57","author":"Vekic DA","year":"2018","unstructured":"Vekic DA, Woods J, Lin P, Cains GD. SAPHO syndrome associated with hidradenitis suppurativa and pyoderma gangrenosum successfully treated with adalimumab and methotrexate: a case report and review of the literature. Int J Dermatol. 2018, 57:10-8. 10.1111\/ijd.13740","journal-title":"Int J Dermatol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21217873","article-title":"Paradoxical psoriasis induced by anti-TNF\u03b1 treatment: evaluation of disease-specific clinical and genetic markers","volume":"21","author":"Bucalo A","year":"2020","unstructured":"Bucalo A, Rega F, Zangrilli A, et al.. Paradoxical psoriasis induced by anti-TNF\u03b1 treatment: evaluation of disease-specific clinical and genetic markers. Int J Mol Sci. 2020, 21:10.3390\/ijms21217873","journal-title":"Int J Mol Sci"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00282","article-title":"Paradoxical skin reactions to biologics in patients with rheumatologic disorders","volume":"10","author":"Garcovich S","year":"2019","unstructured":"Garcovich S, De Simone C, Genovese G, Berti E, Cugno M, Marzano AV. Paradoxical skin reactions to biologics in patients with rheumatologic disorders. Front Pharmacol. 2019, 10:282. 10.3389\/fphar.2019.00282","journal-title":"Front Pharmacol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.10.2008.1145","article-title":"Response to infliximab in SAPHO syndrome","volume":"2009","author":"Fruehauf J","year":"2009","unstructured":"Fruehauf J, Cierny-Modr\u00e8 B, Caelen Lel-S, Schwarz T, Weinke R, Aberer E. Response to infliximab in SAPHO syndrome. BMJ Case Rep. 2009, 2009:10.1136\/bcr.10.2008.1145","journal-title":"BMJ Case Rep"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2018.04.003","article-title":"Biologics in SAPHO syndrome: a systematic review","volume":"48","author":"Daoussis D","year":"2019","unstructured":"Daoussis D, Konstantopoulou G, Kraniotis P, Sakkas L, Liossis SN. Biologics in SAPHO syndrome: a systematic review. Semin Arthritis Rheum. 2019, 48:618-25. 10.1016\/j.semarthrit.2018.04.003","journal-title":"Semin Arthritis Rheum"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1628279","article-title":"Case report: successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome and palmoplantar pustulosis with ustekinumab","volume":"16","author":"Chen L","year":"2025","unstructured":"Chen L, Liang Q, Chen S, Cheng H. Case report: successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome and palmoplantar pustulosis with ustekinumab. Front Immunol. 2025, 16:1628279. 10.3389\/fimmu.2025.1628279","journal-title":"Front Immunol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S238843","article-title":"Real-world patient experience of switching biologic treatment in inflammatory arthritis and ulcerative colitis - a systematic literature review","volume":"14","author":"Luttropp K","year":"2020","unstructured":"Luttropp K, Dal\u00e9n J, Svedbom A, Dozier M, Black CM, Puenpatom A. Real-world patient experience of switching biologic treatment in inflammatory arthritis and ulcerative colitis - a systematic literature review. Patient Prefer Adherence. 2020, 14:309-20. 10.2147\/PPA.S238843","journal-title":"Patient Prefer Adherence"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.911922","article-title":"SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: a case report","volume":"13","author":"Yuan F","year":"2022","unstructured":"Yuan F, Luo J, Yang Q. SAPHO syndrome complicated by ankylosing spondylitis successfully treated with tofacitinib: a case report. Front Immunol. 2022, 13:911922. 10.3389\/fimmu.2022.911922","journal-title":"Front Immunol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-023-02488-z","article-title":"A systematic review of the economic and health-related quality of life impact of advanced therapies used to treat moderate-to-severe ulcerative colitis","volume":"40","author":"Cichewicz A","year":"2023","unstructured":"Cichewicz A, Tencer T, Gupte-Singh K, Egodage S, Burnett H, Kumar J. A systematic review of the economic and health-related quality of life impact of advanced therapies used to treat moderate-to-severe ulcerative colitis. Adv Ther. 2023, 40:2116-46. 10.1007\/s12325-023-02488-z","journal-title":"Adv Ther"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber W","year":"2012","unstructured":"Hueber W, Sands BE, Lewitzky S, et al.. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut. 2012, 61:1693-700. 10.1136\/gutjnl-2011-301668","journal-title":"Gut"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14565","article-title":"Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome associated with inflammatory bowel disease: report of four patients","volume":"26","author":"Ma M","year":"2023","unstructured":"Ma M, Liu Y, Liu S, Li C. Synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome associated with inflammatory bowel disease: report of four patients. Int J Rheum Dis. 2023, 26:996-9. 10.1111\/1756-185X.14565","journal-title":"Int J Rheum Dis"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0760-z","article-title":"Successful treatment of SAPHO syndrome with an oral bisphosphonate","volume":"29","author":"Ichikawa J","year":"2009","unstructured":"Ichikawa J, Sato E, Haro H, Ando T, Maekawa S, Hamada Y. Successful treatment of SAPHO syndrome with an oral bisphosphonate. Rheumatol Int. 2009, 29:713-5. 10.1007\/s00296-008-0760-z","journal-title":"Rheumatol Int"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3390\/gastroent12020020","article-title":"Patient-reported outcomes in inflammatory bowel disease: a measurement of effect in research and clinical care","volume":"12","author":"Fletcher J","year":"2021","unstructured":"Fletcher J, Cooper SC, Swift A. Patient-reported outcomes in inflammatory bowel disease: a measurement of effect in research and clinical care. Gastroenterol Insights. 2021, 12:225-37. 10.3390\/gastroent12020020","journal-title":"Gastroenterol Insights"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.05.006","article-title":"The SAPHO syndrome","volume":"42","author":"Nguyen MT","year":"2012","unstructured":"Nguyen MT, Borchers A, Selmi C, Naguwa SM, Cheema G, Gershwin ME. The SAPHO syndrome. Semin Arthritis Rheum. 2012, 42:254-65. 10.1016\/j.semarthrit.2012.05.006","journal-title":"Semin Arthritis Rheum"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(99)80027-4","article-title":"SAPHO syndrome: a long-term follow-up study of 120 cases","volume":"29","author":"Hayem G","year":"1999","unstructured":"Hayem G, Bouchaud-Chabot A, Benali K, et al.. SAPHO syndrome: a long-term follow-up study of 120 cases. Semin Arthritis Rheum. 1999, 29:159-71. 10.1016\/S0049-0172(99)80027-4","journal-title":"Semin Arthritis Rheum"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/407993-from-the-gut-to-the-bone-a-narrative-review-of-the-synovitis-acne-pustulosis-hyperostosis-and-osteitis-sapho-inflammatory-bowel-disease-ibd-overlap-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T17:44:27Z","timestamp":1757785467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/407993-from-the-gut-to-the-bone-a-narrative-review-of-the-synovitis-acne-pustulosis-hyperostosis-and-osteitis-sapho-inflammatory-bowel-disease-ibd-overlap-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,13]]},"references-count":75,"URL":"https:\/\/doi.org\/10.7759\/cureus.92230","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,13]]}}}